March 13 (Reuters) - Australian Pharmaceutical Industries Ltd (API) :
- CLEAR THAT API'S NBIO TO PURSUE A MERGER OF API AND SIGMA IS UNABLE TO BE TAKEN FORWARD
- IS REVIEWING ITS SHAREHOLDING IN SIGMA WHICH IT ACQUIRED IN LATTER PART OF 2018
- API HAS CLOSED ITS DATA ROOM AND IS REVIEWING ITS SHAREHOLDING IN SIGMA WHICH IT ACQUIRED IN LATTER PART OF 2018
Source text (http//bit.ly/2TAOoZ4)
(([email protected];))
